• SENSEX 80,567.71
    409.83 (+0.51%)
  • BANKNIFTY 54,067.55
    406.55 (+0.76%)
  • Ola Electric
    70.25 123.90(%)
  • N S D L
    1,236.20 880.00(%)
  • Aditya Vision
    447.00 328.25(%)
  • Vimta Labs
    829.00 787.20(%)
  • One Mobikwik
    300.00 698.30(%)
  • Tata Steel
    168.00 170.20(%)
  • Netweb Technol.
    2,564.75 3,060.00(%)
  • Apollo Micro Sys
    306.60 298.70(%)
  • Aurobindo Pharma
    1,041.00 1,592.55(%)
  • Jai Corp
    170.15 406.00(%)
  • Moschip Tech.
    196.45 279.00(%)
  • Godfrey Phillips
    10,420.00 11,462.00(%)
  • Yes Bank
    20.38 24.40(%)
  • M & M
    3,292.60 3,430.10(%)
  • NTPC
    333.45 292.70(%)
  • TBO Tek
    1,609.20 2,000.00(%)
  • AU Small Finance
    716.05 840.95(%)
  • Larsen & Toubro
    3,606.35 3,963.00(%)
  • TCS
    3,087.75 2,992.05(%)
  • Bharat Electron
    381.05 435.95(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Dipna Pharmachem Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 77240.0
  • ISIN : INE0MC401013
20.22 -1 (-3.35%)
  • As on 03 Sep 2025 (EOD)
  • Today’s Low

    20.11
  • Today’s High

    21.96
  • Open

    21.96
  • Perv Close

    20.92
  • 52W Low

    6.40
  • 52W High

    26.31

Key Indicators

  • P/E(TTM)

    51.02

  • Mar.Cap (₹Cr.)

    50.30

  • Div & Yield %

    0.00

  • Book Value(₹)

    16.01

  • Debt-Equity Ratio

    -3.35

  • AGM Date

    03-Sep-2025

  • EPS

    0.41

  • P/E Ratio

    51.02

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    50.30

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    24.05

  • BV (₹)

    16.00

  • Sales( ₹ in Cr.)

    124.92

  • NP (in Cr.)

    0.97

  • NP Var(%)

    -10.0

  • Div%

    0.0

  • CPS (₹)

    0.40

  • EPS (₹)

    0.40

  • Traded Value (₹ in Lakhs)

    50.30

  • 52 Week High

    26.31

  • 52 Week Low

    6.40

  • Price BSE

    21.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    50.30

  • P/C Ratio

    51.20

  • P/E Ratio

    51.80

  • Price Vs.BV

    0.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 124.92 164.34 99.93 72.76 31.00 30.54
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 124.92 164.34 99.93 72.76 31.00 30.54
Other Income 0.01 0.00 0.01 0.01 0.02 0.01
Stock Adjustments -9.95 18.44 12.64 -0.89 1.64 2.22
Total Income 114.98 182.78 112.58 71.88 32.66 32.77
EXPENDITURE :            
Raw Materials 103.78 176.35 108.13 67.67 31.22 31.16
Power and Fuel Cost 0.01 0.01 0.00 0.00 0.00 0.00
Employee Cost 0.41 0.44 0.00 0.00 0.41 0.38
Other Manufacturing Expenses 0.08 0.07 0.11 0.31 0.04 0.03
Selling and Administration Expenses 6.90 2.35 1.92 1.66 0.54 0.61
Miscellaneous Expenses 0.05 0.12 0.05 0.05 0.03 0.11
Employee Benefit Expenses 0.41 0.44 0.00 0.00 0.41 0.38
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 111.23 179.33 110.21 69.69 32.24 32.30
Operating Profit 3.75 3.45 2.36 2.19 0.41 0.46
Interest 2.32 2.01 0.97 0.61 0.35 0.39
Gross Profit 1.43 1.44 1.39 1.58 0.06 0.07
Depreciation 0.01 0.02 0.01 0.01 0.01 0.01
Profit Before Tax 1.42 1.42 1.38 1.57 0.05 0.06
Current Tax 0.45 0.34 0.47 0.41 0.03 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit 0.97 1.09 0.91 1.17 0.02 0.06
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 0.97 1.09 0.91 1.17 0.02 0.06
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 2.15 1.06 1.48 0.31 0.29 0.23
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 1.33 0.00 0.00 0.00
P & L Balance carried down 3.12 2.15 1.06 1.48 0.31 0.29
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.41 0.45 0.76 333.39 6.91 16.86
Earnings Per Share(Adj)-Unit Curr 0.41 0.45 0.62 - - -
Book Value 16.01 15.60 20.35 496.73 163.34 156.43
Book Value(Adj)-Unit Curr 16.01 15.60 16.72 - - -

Shareholding Pattern

  • Promoter Group

    9.98%

  • Public Share Holding

    90.02%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,399,700 9.98 2,399,700 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,399,700 9.98 2,399,700 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 1,102,000 4.58 1,102,000 14
Clearing Members 4,250 0.02 4,250 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,587,250 6.60 1,587,250 33
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,830,250 7.61 1,830,250 104
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 9,960,460 41.42 9,960,460 120
Individuals holding nominal share capital up to Rs. 1 lakh 7,161,340 29.78 7,161,340 1,720
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 21,645,550 90.02 21,645,550 1,993
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 24,045,250 100.00 24,045,250 1,997

Company Background

Dipna Pharmachem LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Dipna Pharmachem Ltd
  • BSE Code : 77240.0
  • ISIN : INE0MC401013
  • Incorporation Year

    2011

  • Registered Office

    A/211 Siddhi Vinayak Complex
    Near D A V School Makarba, Ahmedabad,
    Gujarat-380055

  • Telephone

    91-079-9898066121

  • FAX

  • Chairman

    Dipna Shah

  • Managing Director

    Keyur Shah

  • Company Secretary

  • Auditor

    Devadiya & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No 56-2 ,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Dipna Pharmachem Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Dipna Pharmachem 20.92 124.93 124.92 51.02 6.64
Abbott India 32,356.30 6,684.73 6,409.15 47.34 44.95
Astrazeneca Phar 8,937.85 1,756.92 1,716.29 121.87 32.94
P & G Health Ltd 6,321.25 944.52 934.17 34.91 40.23
Glaxosmi. Pharma 2,749.15 3,866.05 3,723.49 49.44 58.72
Cipla 1,568.95 20,029.57 19,044.85 23.45 21.40
Amrutanjan Healt 729.20 469.50 451.82 38.66 21.89
Guj. Themis Bio. 376.95 152.47 150.80 92.16 27.21
Fermenta Biotec. 328.45 442.21 430.53 10.90 17.61
Bliss GVS Pharma 159.40 703.42 667.20 23.83 9.16
Ambalal Sarabhai 32.71 19.33 4.04 17.13 2.10